Cargando…

ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types

Anti-silencing function 1B histone chaperone (ASF1B) is known to be an important modulator of oncogenic processes, yet its role in lung adenocarcinoma (LUAD) remains to be defined. In this study, an integrated assessment of The Cancer Genome Atlas (TCGA) and genotype-tissue expression (GTEx) dataset...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wencheng, Gao, Zhouyong, Guan, Mingxiu, Liu, Ning, Meng, Fanjie, Wang, Guangshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459715/ https://www.ncbi.nlm.nih.gov/pubmed/34568067 http://dx.doi.org/10.3389/fonc.2021.731547

Ejemplares similares

The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma
por: Zhang, Zifa, et al.
Publicado: (2023)

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
por: Zhu, Huaxin, et al.
Publicado: (2022)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
por: Albahde, Mugahed Abdullah Hasan, et al.
Publicado: (2020)

ASF1B acted as a prognostic biomarker for stomach adenocarcinoma
por: Zhao, Cailing, et al.
Publicado: (2023)

ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
por: Ouyang, Xiaoxi, et al.
Publicado: (2022)

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment
por: Ma, Jing, et al.
Publicado: (2021)

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
por: Kostyrko, Kaja, et al.
Publicado: (2023)

A SUMOylation Motif in Aurora-A: Implications for Spindle Dynamics and Oncogenesis
por: Pérez de Castro, Ignacio, et al.
Publicado: (2011)

Dynamic Activity of Histone H3-Specific Chaperone Complexes in Oncogenesis
por: Wen, Ting, et al.
Publicado: (2022)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

HMOX1 promotes lung adenocarcinoma metastasis by affecting macrophages and mitochondrion complexes
por: Chen, Bo, et al.
Publicado: (2022)

Research priorities to fill knowledge gaps on ASF seasonality that could improve the control of ASF
por: Nielsen, Søren Saxmose, et al.
Publicado: (2021)

ASF1B promotes cervical cancer progression through stabilization of CDK9
por: Liu, Xinjian, et al.
Publicado: (2020)

The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
por: Abbas, Wasim, et al.
Publicado: (2015)

Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis
por: Del Valle, Luis, et al.
Publicado: (2019)

A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression
por: Hartl, Markus, et al.
Publicado: (2019)

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
por: Duan, Xiaofeng, et al.
Publicado: (2021)

Eukaryotic Initiation Factor 4A-3: A Review of Its Physiological Role and Involvement in Oncogenesis
por: Ye, Jiazhou, et al.
Publicado: (2021)

Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far
por: Prasad, Shashanka K., et al.
Publicado: (2022)

Distinct role of histone chaperone Asf1a and Asf1b during fertilization and pre-implantation embryonic development in mice
por: Wang, Xuemei, et al.
Publicado: (2021)

miR-1323 Promotes Cell Migration in Lung Adenocarcinoma by Targeting Cbl-b and Is an Early Prognostic Biomarker
por: Zhao, Huan, et al.
Publicado: (2020)

A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses
por: Zhang, Wenlong, et al.
Publicado: (2023)

Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma
por: Li, Xinge, et al.
Publicado: (2022)

African Swine Fever (ASF) and Ticks. No Risk of Tick-mediated ASF Spread in Poland and Baltic States
por: Frant, Maciej, et al.
Publicado: (2017)

Genetic Diversity in Normal Cell Populations is the Earliest Stage of Oncogenesis Leading to Intra-Tumor Heterogeneity
por: Howk, Cory L., et al.
Publicado: (2013)

UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway
por: Li, Yongmeng, et al.
Publicado: (2023)

The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis
por: Weekes, Colin D., et al.
Publicado: (2011)

Tumor Endothelial Marker 8 Promotes Proliferation and Metastasis via the Wnt/β-Catenin Signaling Pathway in Lung Adenocarcinoma
por: Ding, Chen, et al.
Publicado: (2021)

Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and Adenocarcinoma
por: Lin, Dan-dan, et al.
Publicado: (2019)

CaSR Induces Osteoclast Differentiation and Promotes Bone Metastasis in Lung Adenocarcinoma
por: Liu, Lian, et al.
Publicado: (2020)

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1
por: Sen, Siddhartha P, et al.
Publicado: (2006)

RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2021)

MYC/MAX-Activated LINC00958 Promotes Lung Adenocarcinoma by Oncogenic Transcriptional Reprogramming Through HOXA1 Activation
por: Zhang, Tao, et al.
Publicado: (2022)

Papillary Adenocarcinoma: A Rare Subtype of Lung Adenocarcinoma
por: Thouil, Afaf, et al.
Publicado: (2023)

WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma
por: Gong, Lian, et al.
Publicado: (2020)

Upregulation of XIAP promotes lung adenocarcinoma brain metastasis by modulating ceRNA network
por: Wang, Yingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f1j1hb5jqd5mrgvjkfja6e41hj